| Literature DB >> 34179564 |
Maria Laura Ricardo-Silgado1, Alison McRae1, Andres Acosta1.
Abstract
Enteroendocrine cells (EECs) are specialized cells that are widely distributed throughout the gastrointestinal tract. EECs sense luminal content and release hormones, such as: ghrelin, cholecystokinin, glucagon like peptide 1, peptide YY, insulin like peptide 5, and oxyntomodulin. These hormones can enter the circulation to act on distant targets or act locally on neighboring cells and neuronal pathways to modulate food digestion, food intake, energy balance and body weight. Obesity, insulin resistance and diabetes are associated with alterations in the levels of enteroendocrine hormones. Evidence also suggests that modified regulation and release of gut hormones are the result of compensatory mechanisms in states of excess adipose tissue and hyperglycemia. This review collects the evidence available detailing pathophysiological alterations in enteroendocrine hormones and their association with appetite, obesity and glycemic control.Entities:
Keywords: Appetite; Diabetes; Enteroendocrine hormones; Obesity
Year: 2021 PMID: 34179564 PMCID: PMC8224828 DOI: 10.1016/j.obmed.2021.100332
Source DB: PubMed Journal: Obes Med ISSN: 2451-8476